These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18376420)

  • 1. Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes.
    Wu MS; Liang JT; Lin YD; Wu ET; Tseng YZ; Chang KC
    Br J Pharmacol; 2008 Jun; 154(4):758-64. PubMed ID: 18376420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetyl-l-carnitine and oxfenicine on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar rats.
    Wang CH; Wang SS; Ko WJ; Chen YS; Chang CY; Chang RW; Chang KC
    PLoS One; 2013; 8(7):e69977. PubMed ID: 23922880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systolic elastance and resistance in the regulation of cardiac pumping function in early streptozotocin-diabetic rats.
    Chang KC; Lo HM; Tseng YZ
    Exp Biol Med (Maywood); 2002 Apr; 227(4):251-9. PubMed ID: 11910047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
    Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
    Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoguanidine prevents fructose-induced deterioration in left ventricular-arterial coupling in Wistar rats.
    Chang KC; Liang JT; Tseng CD; Wu ET; Hsu KL; Wu MS; Lin YT; Tseng YZ
    Br J Pharmacol; 2007 Jun; 151(3):341-6. PubMed ID: 17401443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.
    Chang KC; Hsu KL; Tseng CD; Lin YD; Cho YL; Tseng YZ
    Br J Pharmacol; 2006 Apr; 147(8):944-50. PubMed ID: 16491102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoguanidine prevents age-related deterioration in left ventricular-arterial coupling in Fisher 344 rats.
    Chang KC; Hsu KL; Chou TF; Lo HM; Tseng YZ
    Br J Pharmacol; 2004 Aug; 142(7):1099-104. PubMed ID: 15249427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal changes in cardiac force- and flow-generation capacity, loading conditions, and mechanical efficiency in streptozotocin-induced diabetic rats.
    Yeih DF; Lin LY; Yeh HI; Lai YJ; Chiang FT; Tseng CD; Chu SH; Tseng YZ
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H867-74. PubMed ID: 18055519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylprednisolone Protects Cardiac Pumping Mechanics from Deteriorating in Lipopolysaccharide-Treated Rats.
    Ko YH; Tsai MS; Chang RW; Chang CY; Wang CH; Wu MS; Liang JT; Chang KC
    Front Physiol; 2015; 6():348. PubMed ID: 26635633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress.
    Pei Z; Deng Q; Babcock SA; He EY; Ren J; Zhang Y
    Toxicol Lett; 2018 Mar; 284():10-20. PubMed ID: 29174818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats.
    Norton GR; Candy G; Woodiwiss AJ
    Circulation; 1996 May; 93(10):1905-12. PubMed ID: 8635270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoguanidine prevents fructose-induced arterial stiffening in Wistar rats: aortic impedance analysis.
    Lin YT; Tseng YZ; Chang KC
    Exp Biol Med (Maywood); 2004 Nov; 229(10):1038-45. PubMed ID: 15522840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats.
    Chang GJ; Yeh YH; Chen WJ; Ko YS; Pang JS; Lee HY
    J Pharmacol Exp Ther; 2019 Jan; 368(1):66-78. PubMed ID: 30381326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes.
    Chang KC; Tseng CD; Chou TF; Cho YL; Chi TC; Su MJ; Tseng YZ
    Eur J Clin Invest; 2006 Jan; 36(1):1-7. PubMed ID: 16403003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of C36, a novel breaker of advanced glycation endproducts cross-links, on the cardiovascular system of diabetic rats.
    Cheng G; Wang LL; Long L; Liu HY; Cui H; Qu WS; Li S
    Br J Pharmacol; 2007 Dec; 152(8):1196-206. PubMed ID: 17965740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethylthiourea normalizes velocity-dependent, but not force-dependent, index of ventricular performance in diabetic rats: role of myosin heavy chain isozyme.
    Yeih DF; Yeh HI; Hsin HT; Lin LY; Chiang FT; Tseng CD; Chu SH; Tseng YZ
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1411-20. PubMed ID: 19633204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of methoxamine on left ventricular-arterial coupling in streptozotocin-diabetic rats: a pressure-volume analysis.
    Peng YI; Chang KC
    Can J Physiol Pharmacol; 2000 May; 78(5):415-22. PubMed ID: 10841437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats.
    Hoit BD; Castro C; Bultron G; Knight S; Matlib MA
    J Card Fail; 1999 Dec; 5(4):324-33. PubMed ID: 10634674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes.
    Cartledge JJ; Eardley I; Morrison JF
    BJU Int; 2001 Mar; 87(4):402-7. PubMed ID: 11251537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen.
    Chang KC; Liang JT; Tsai PS; Wu MS; Hsu KL
    Br J Pharmacol; 2009 Aug; 157(8):1419-26. PubMed ID: 19681870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.